Meet the women breaking down barriers and shaping the future of physics in India
Meeting Announcement
Researchers from The University of Texas MD Anderson Cancer Center will present breakthrough studies at the American Association for Cancer Research (AACR) Annual Meeting 2026.
The International Society for Stem Cell Research (ISSCR) announces that Stem Cell Reports, its official open-access, peer-reviewed journal, has been named the official journal of the BaCell 3D Organoid Conference, taking place 22-24 June 2026 in Basel, Switzerland.
BaCell 3D brings together leading scientists, innovators, and industry experts at the forefront of organoid technologies, microphysiological systems, and disease modeling. Held annually in one of Europe’s most vibrant life science hubs, the meeting fosters global collaboration and accelerates advances in in vitro multicellular systems that are transforming biomedical research.
Baroness Natalie Bennett will join leading scientists and policymakers in Belfast for a discussion on how to slow the spread of superbugs at the Microbiology Society’s Annual Conference.
Europe’s dependence on fossil fuels is not only making the continent economically and politically vulnerable, it also has dramatic consequences for the population’s health. Growing air pollution, heat damage and the climate-related spread of infectious diseases are looming, warns the 2026 Europe Report of the Lancet Countdown on Health and Climate Change, which its co-directors Prof. Dr Joacim Rocklöv (Heidelberg University) and Prof. Dr Cathryn Tonne (Barcelona Institute for Global Health) are about to present to the public. Together with other experts from academia, practice and policy they will discuss the report’s results during a public event at Heidelberg University, comparing the current findings with successful measures for climate action and health protection. The launch event with livestreaming is to take place on 22 April 2026.
The 2026 season of the Pharma.AI webinar series will showcase the ongoing AI revolution in life sciences, including the increased interest in the use of foundation models why specialized models remain essential for biology, chemistry, and translational research; How Pharma.AI brings together foundation models and scientific AI agents within a unified AI-driven workflow for drug R&D and scientific research; and how Insilico’s leading “AI trains AI” approach may enable foundation models to be better adapted for scientific and drug discovery applications, accelerating the evolution of AI decision-making systems.